1. Market Research
  2. > Healthcare
  3. > Medical Device Market Trends

Analysis of the Global Orthopedic Implant Market : Potential Growth in a Mature Market

  • October 2014
  • 91 pages
  • Frost & Sullivan
Report ID: 2466777

Summary

Table of Contents

Methodology

•The information contained in this research service was derived from a variety of relevant primary and secondary sources.
•During primary research, contact lists were drawn up, and interviews were arranged with known industry and end-user contacts. Internal Frost & Sullivan resources and databases were also used to establish market straw models for subsequent validation. Primary sources included:
oProduct managers, marketing managers, marketing directors, heads of business development, the R&D community, trade and industry associations, and opinion leaders.
•Secondary data sources included:
oCompany publications (annual reports, U.S. Securities and Exchange Commission (SEC) filings, investor presentations, earnings transcripts, and press releases), U.S. Government public sources (clinicaltrials.gov, FDA.gov, and Orange Book), medical device databases, Bloomberg, and published articles in scientific and medical journals.
•The forecasting tool Frost & Sullivan used is based on the following:
oEconometric model, quantitative market input, and qualitative trends that influence growth rate.
•Revenue forecasting was performed using a robust, data-driven, bottom-up approach that utilizes cross-validation and unique industry relationships.

Key Findings

•The orthopedic industry trend toward customizable medicine is supported by customer expectation of greater comfort with a wider range of motion and physician desire for an improved outcome provided by a better-fitting implant.
•There is a growing focus on the healthcare industry and the indispensability of implants in degenerative and chronic disorders.
•With improved fit and more successful surgical outcomes, implants can reduce the long-term treatment cost of conditions like chronic osteoarthritis.
•As it becomes better understood, clinical research around biologics is moving from theoretical science to real-world solutions, with increased funding fueling a steady growth rate in the United States. A global compound annual growth rate (CAGR) of xx% is anticipated from 2013 to 2021.
•Companies are moving toward a more diversified portfolio to offset the slow growth rates in the joint reconstruction and the spine segments, which are anticipated to witness global CAGRs of xx% and xx%, respectively.
•Company and physician interest in advanced intraoperative imaging and robotic assistance, as future developments, includes bio-printed tissues, bionic prosthetics, and enhanced diagnosis.
•Given the maturity of established markets, and with a growth rate of xx% in 2013, companies are looking for new opportunities in services, solutions, and supply chain efficiency.
•Revenue is shifting to emerging markets, with growth rates that are xx– times higher than in the United States and Western Europe.

Scope and Segmentation

•This study evaluates the global market for orthopedic implants in the following segments: Joint reconstruction, spine, trauma, and orthobiologics.
•The orthopedic implant market is stable in the United States and Western Europe; however, it is growing in emerging markets, such as Asia-Pacific (Australia, South Korea, Japan, Taiwan, and South East Asia), Brazil, Russia, India, and China (BRIC), Mexico, and Turkey.
•Western Europe includes Benelux, Germany, France, Italy, Scandinavia, Spain, and the United Kingdom.
•Indication-specific annual revenue, as reported, is used when available. Otherwise, estimates are used.
•When referring to U.S. dollars, M = Millions and B = Billions.

Key Questions This Study Will Answer

Where is the market growing, how long will it continue to grow, and at what rate?
What are the shifts in global market strategies?
How are market disruptors and enterprising changes influencing niche companies?
What dynamics are causing shifts in future technologies and trends?
Are the products/services offered today meeting customer needs, or is additional development required?

CEO’s Perspective

Infrastructure must be developed and resources must be shifted to better serve emerging markets that have a CAGR comparable to the United States, at xx%.
More robust minimally invasive surgery (MIS) portfolios must be developed by acquiring innovative competitors to meet growing customer and physician demands.
A strong pipeline of leading-edge products, to stimulate future technology advancements, must be developed, especially in segments with limited innovation, such as trauma.
To increase patient access to treatment options to proliferate procedural volumes and stimulate growth in developed and emerging markets, new cost-of-care models must be introduced.
Novel products that offer interoperability and connectivity, adding value to hospital, physician, and patient, must be identified.

3 Big Predictions

With xx companies accounting for around xx% of the market, consolidation and high-profile acquisitions will continue in 2014.
Robotic surgeries and new image-guided technology continue to grow, with a global market of around $xxB and a potential CAGR of xx%. Most of the revenue is being driven by the United States and Asia-Pacific.
The demand for low-priced joint reconstruction and trauma implants will be driven by the middle class, which will account for xx% of the population by 2020.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Ahmad helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Hematology and Flow Cytometry Analyzers and Reagents Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 47500
  • Industry report
  • May 2017
  • by Venture Planning Group

This 74-country survey from VPGMarketResearch.com provides granular data and analysis not available elsewhere. The survey is designed to help current suppliers and potential market entrants identify and ...

Coagulation Testing Analyzers and Reagents Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 33500
  • Industry report
  • May 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides granular data and analysis not available from any other source. The report explores business and technological trends; provides test volume ...

Hemostasis Diagnostic Analyzers and Reagents Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 33500
  • Industry report
  • June 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides granular data and analysis not available from any other source. The report explores business and technological trends; provides test volume ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.